The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study
Abstract
Left ventricular hypertrophy (LVH) and inflammation independently increase risk for death in people who receive hemodialysis. A nonrandomized, controlled trial was conducted of the effect of short daily (6 sessions/wk of 3 h each) or conventional (three sessions/wk of 4 h each) hemodialysis on LVH and inflammatory factors. A total of 26 short daily hemodialysis and 51 matched conventional hemodialysis patients were enrolled, and baseline and 12-mo measures of echocardiographic left ventricular mass index (LVMI), serum C-reactive protein (CRP), serum calcium and phosphorus, and erythropoietin resistance index were collected. Baseline characteristics were similar between groups except that hemoglobin and serum calcium were lower and serum phosphorus was higher in the short daily hemodialysis group. At 12-mo follow-up, short daily hemodialysis patients experienced a 30% decrease in LVMI (154 +/- 33 to 108 +/- 25; P < 0.0001). After adjustment for potential confounders, short daily hemodialysis (beta = -41.63, P = 0.03) and percentage decrease in serum phosphorus (beta = -0.12, P = 0.04) predicted a 12-mo decrease in LVMI. Among short daily hemodialysis patients, there were significant reductions in median CRP levels [1.22 interquartile range (IQR) (0.37 to 3.70) to 0.05 IQR (0.05 to 1.17); P < 0.01] and erythropoietin resistance index [19.5 IQR (8.6 to 37.6) to 10.5 IQR (5.5 to 14.6); P < 0.001]. There were no significant changes in LVMI, CRP, or erythropoietin resistance index in the conventional hemodialysis group. Short daily hemodialysis is associated with improved fluid and phosphorus management and a reduction in LVH and inflammatory factors compared with conventional hemodialysis. Future trials are needed to determine whether short daily hemodialysis can reduce morbidity and mortality in this high-risk population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,485
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., & Wanner, C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00273.x · Cited by 1,531
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
Jono, S., McKee, M. D., Murry, C. E., Shioi, A., Nishizawa, Y., Mori, K., Morii, H., & Giachelli, C. M. (2000) · Circulation Research · doi:10.1161/01.res.87.7.e10 · Cited by 1,427
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H.-Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., & Giachelli, C. M. (2001) · Circulation Research · doi:10.1161/hh2401.101070 · Cited by 822
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.194 · Cited by 492
The prognostic importance of left ventricular geometry in uremic cardiomyopathy.
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122024 · Cited by 480
Calcification of Vascular Smooth Muscle Cell Cultures: Inhibition by Osteopontin
Wada, T., McKee, M. D., Steitz, S., & Giachelli, C. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.166 · Cited by 458
Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis
Chan, C. T., Floras, J. S., Miller, J., Richardson, R., & Pierratos, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00362.x · Cited by 392
A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients
Adragao, T., Pires, A., Lucas, C., Birne, R., Magalhaes, L., Goncalves, M., & Negrao, A. P. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh217 · Cited by 329
Lorenzo, V., Martín, M., Rufino, M., Hernández, D., Torres, A., & Ayus, J. C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.012 · Cited by 240
Self-citationFagugli, R. M., Reboldi, G., Quintaliani, G., Pasini, P., Ciao, G., Cicconi, B., Pasticci, F., Kaufman, J. M., & Buoncristiani, U. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.26103 · Cited by 238
Influence of coexisting disease on survival on renal-replacement therapy
Khan, I. H., Catto, G. R. D., MacLeod, A. M., Edward, N., Fleming, L. W., & Henderson, I. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)93003-j · Cited by 236
Ganesh, S. K., Hulbert-Shearon, T., Port, F. K., Eagle, K., & Stack, A. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000043140.23422.4f · Cited by 227
Inflammatory signals associated with hemodialysis
Caglar, K., Peng, Y., Pupim, L. B., Flakoll, P. J., Levenhagen, D., Hakim, R. M., & Ikizler, T. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00556.x · Cited by 181
Foley, R. N. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.160271.x · Cited by 171
Ting, G. O., Kjellstrand, C., Freitas, T., Carrie, B. J., & Zarghamee, S. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.020 · Cited by 168
Chan, C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.8.1518 · Cited by 163
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
Wanner, C., & Metzger, T. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_8.29 · Cited by 148
McCullough, P. A., Sandberg, K. R., Dumler, F., & Yanez, J. E. (2004) · Journal of Nephrology · doi:10.1093/joneph/17.2.205 · Cited by 147
Pathophysiology of cardiovascular disease in hemodialysis patients
Meeus, F., KOURILSKY, O., Guérin, A. P., Gaudry, C., Marchais, S. J., & London, G. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07618.x · Cited by 128
Chan, C. T., Hanly, P., Gabor, J. Y., Picton, P. E., Pierratos, A., & Floras, J. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00384.x · Cited by 122
Silent infection in clotted hemodialysis access grafts.
Ayus, J. C., & Sheikh‐Hamad, D. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971314 · Cited by 121
Self-citationContinuous quality improvement: DOQI becomes K/DOQI and is updated
Eknoyan, G., Levin, N. W., Eschbach, J. W., Golper, T. A., Owen, W. F., Schwab, S., & Steinberg, E. P. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80074-3 · Cited by 88
Causes and therapy of microinflammation in renal failure
Schindler, R. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1054 · Cited by 77
Ayus, J. C., & Achinger, S. G. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18304.x · Cited by 58
Self-citationRole of Inflammation and Its Treatment in ESRD Patients
Kaysen, G. A. (2002) · Blood Purification · doi:10.1159/000046988 · Cited by 54
Martínez-Vea, A., Bardajı́, A., García, C., Ridao, C., Richart, C., & Oliver, J. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80453-7 · Cited by 53
Ishimura, E., Taniwaki, H., Tabata, T., Tsujimoto, Y., Jono, S., Emoto, M., Shoji, T., Inaba, M., Inoue, T., & Nishizawà, Y. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.008 · Cited by 50
Left ventricular hypertrophy: why does it happen?
London, G. M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg1083 · Cited by 41
Cited by
Hofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
In-Center Hemodialysis Six Times per Week versus Three Times per Week
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001593 · Cited by 1,008
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Alp Ikizler, T., Cano, N. J., Franch, H., Fouque, D., Himmelfarb, J., Kalantar-Zadeh, K., Kuhlmann, M. K., Stenvinkel, P., TerWee, P., Teta, D., et al. (2013) · Kidney International · doi:10.1038/ki.2013.147 · Cited by 722
Culleton, B. F., Walsh, M., Klarenbach, S. W., Mortis, G., Scott-Douglas, N., Quinn, R. R., Tonelli, M., Donnelly, S., Friedrich, M. G., Kumar, A., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1291 · Cited by 683
Metadata
- Authors
- Ayus, J. C., Mizani, M. R., Achinger, S. G., Thadhani, R., Go, A. S., & Lee, S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-09
- Volume
- 16
- Issue
- 9
- Pages
- 2778-2788
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2109012519
- Cited by
- 265
- References
- 34
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.